- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03196908
Impact of Energy Drink Brands on Heart Rhythm
December 20, 2018 updated by: University of the Pacific
Impact of Energy Drink Brands on Heart Rhythm in Healthy Volunteers: A Randomized Controlled Trial
To assess the cardiac effects of energy drink brands in healthy volunteers
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Energy drinks are widely available and globally consumed.
There are many brands of energy drinks on the market, and there are differences in the ingredients included.
Previous studies have tried to evaluate the safety of energy drinks and have demonstrated a signal for some electrocardiographic (ECG) and hemodynamic effects.
However, product related differences need further exploration.
This study is designed to assess the effects of 2 different energy drink products on heart rhythm and blood pressure in healthy subjects.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stockton, California, United States, 95211
- University of the Pacific
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy male or female adults 18 - 40 years old
- Participants must be willing to refrain from caffeine and alcohol use ≥48 hours prior to sessions on Day 1, 8, and 15
Exclusion Criteria:
- Presence of any known medical condition confirmed through participant interview
- QTc interval greater than 450 milliseconds (ms).
- Blood pressure greater than 140/90 mmHg.
- Current smokers
- Concurrent use of prescription, over-the-counter (OTC) or herbal supplements taken on a daily basis (except oral contraceptives).
- Pregnant or currently breast-feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Energy Drink Brand 1
Two 16-oz bottles of Energy Drink Brand 1
|
Two 16-oz containers of Energy Drink Brand 1 consumed in 60 minutes
|
|
Experimental: Energy Drink Brand 2
Two 16-oz bottles of Energy Drink Brand 2
|
Two 16-oz containers of Energy Drink Brand 2 consumed in 60 minutes
|
|
Placebo Comparator: Placebo
Two 16-oz bottles that each contain 390 ml of carbonated water, 20 ml of reconstituted lime juice, and 70 ml of cherry flavoring
|
Lime juice, water, and cherry flavoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Corrected QT (QTc) Interval
Time Frame: 4 hours
|
Electrocardiograph (ECG) Parameters
|
4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
QT
Time Frame: 4 hours
|
Electrocardiograph (ECG) Parameters
|
4 hours
|
|
PR
Time Frame: 4 hours
|
Electrocardiograph (ECG)Parameters
|
4 hours
|
|
QRS
Time Frame: 4 hours
|
Electrocardiograph (ECG) Parameters
|
4 hours
|
|
Heart Rate (HR)
Time Frame: 4 hours
|
Electrocardiograph (ECG) Parameters
|
4 hours
|
|
Central blood pressure
Time Frame: 4 hours
|
Hemodynamic Parameters
|
4 hours
|
|
Peripheral blood pressure
Time Frame: 4 hours
|
Hemodynamic Parameters
|
4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sachin Shah, PharmD, University of the Pacific
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2017
Primary Completion (Actual)
December 30, 2017
Study Completion (Actual)
December 30, 2017
Study Registration Dates
First Submitted
June 20, 2017
First Submitted That Met QC Criteria
June 21, 2017
First Posted (Actual)
June 23, 2017
Study Record Updates
Last Update Posted (Actual)
December 24, 2018
Last Update Submitted That Met QC Criteria
December 20, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17-109
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
GE HealthcareCompleted
-
Taiwan Biophotonic CorporationCompletedBlood Pressure | Blood Pressure VariabilityTaiwan
-
Université de SherbrookeRecruitingBlood Pressure | Blood Pressure Monitoring, Ambulatory | Blood Pressure, High | Blood Pressure ManagementCanada
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
Centre Hospitalier Universitaire VaudoisRecruitingBlood Pressure | Blood Pressure DisordersSwitzerland
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
Istituto Auxologico ItalianoCompletedArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
Clinical Trials on Energy Drink Brand 1
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Université de MontréalUnknown
-
David Grant U.S. Air Force Medical CenterCompletedQTc IntervalUnited States
-
Utrecht Institute for Pharmaceutical SciencesRed Bull GmbHCompleted
-
Karolinska InstitutetRegion Stockholm; Research department, Ersta HospitalTerminated
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Fundació Institut Germans Trias i PujolPlan Nacional sobre DrogasRecruitingAlcohol Drinking | Healthy Adult Participants | Energy Drinks | Binge Alcohol ConsumptionSpain